S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
Log in

NASDAQ:CSIICardiovascular Systems Stock Price, Forecast & News

$27.86
-0.89 (-3.10 %)
(As of 07/15/2020 04:00 PM ET)
Add
Compare
Today's Range
$27.70
Now: $27.86
$30.52
50-Day Range
$28.75
MA: $34.14
$41.50
52-Week Range
$26.00
Now: $27.86
$55.22
Volume588,800 shs
Average Volume338,855 shs
Market Capitalization$982.73 million
P/E RatioN/A
Dividend YieldN/A
Beta1.47
Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral, Predator 360, Stealth 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral, Diamondback 360 2.00 Peripheral, Diamondback 360 200cm Peripheral, and Diamondback 360 180cm Peripheral, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.
Read More
Cardiovascular Systems logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.73 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:CSII
CUSIP14161910
Phone651-259-1600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$248.02 million
Cash Flow$0.09 per share
Book Value$4.25 per share

Profitability

Net Income$-250,000.00

Miscellaneous

Employees652
Market Cap$982.73 million
Next Earnings Date8/4/2020 (Confirmed)
OptionableOptionable

Receive CSII News and Ratings via Email

Sign-up to receive the latest news and ratings for CSII and its competitors with MarketBeat's FREE daily newsletter.

Cardiovascular Systems (NASDAQ:CSII) Frequently Asked Questions

How has Cardiovascular Systems' stock been impacted by COVID-19 (Coronavirus)?

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CSII shares have decreased by 23.3% and is now trading at $27.86. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cardiovascular Systems?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cardiovascular Systems.

When is Cardiovascular Systems' next earnings date?

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Cardiovascular Systems.

How can I listen to Cardiovascular Systems' earnings call?

Cardiovascular Systems will be holding an earnings conference call on Tuesday, August 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems Inc (NASDAQ:CSII) released its earnings results on Tuesday, May, 5th. The medical device company reported ($0.08) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.09) by $0.01. The medical device company had revenue of $61.18 million for the quarter, compared to analysts' expectations of $64 million. Cardiovascular Systems had a negative net margin of 4.04% and a negative return on equity of 7.36%. View Cardiovascular Systems' earnings history.

What price target have analysts set for CSII?

7 Wall Street analysts have issued 1-year target prices for Cardiovascular Systems' stock. Their forecasts range from $44.00 to $58.00. On average, they anticipate Cardiovascular Systems' share price to reach $48.14 in the next year. This suggests a possible upside of 72.8% from the stock's current price. View analysts' price targets for Cardiovascular Systems.

Has Cardiovascular Systems been receiving favorable news coverage?

News coverage about CSII stock has been trending extremely negative this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cardiovascular Systems earned a news impact score of -4.3 on InfoTrie's scale. They also assigned news stories about the medical device company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the stock's share price in the near future. View the latest news about Cardiovascular Systems.

Are investors shorting Cardiovascular Systems?

Cardiovascular Systems saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 1,130,000 shares, a drop of 11.7% from the May 31st total of 1,280,000 shares. Based on an average daily trading volume, of 292,000 shares, the short-interest ratio is presently 3.9 days. Currently, 3.3% of the company's stock are sold short. View Cardiovascular Systems' Current Options Chain.

Who are some of Cardiovascular Systems' key competitors?

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include AbbVie (ABBV), Gilead Sciences (GILD), Netflix (NFLX), Adobe (ADBE), Advanced Micro Devices (AMD), Activision Blizzard (ATVI), Medtronic (MDT), Pfizer (PFE), Procter & Gamble (PG) and Target (TGT).

Who are Cardiovascular Systems' key executives?

Cardiovascular Systems' management team includes the following people:
  • Mr. Scott Raymond Ward M.S., MS, B.Sc., Chairman, Pres & CEO (Age 59)
  • Mr. Jeffrey S. Points, Chief Financial Officer (Age 42)
  • Ms. Rhonda J. Robb, Chief Operating Officer (Age 51)
  • Mr. Alexander Rosenstein, Gen. Counsel & Corp. Sec. (Age 47)
  • Ms. Laura J. Gillund, Chief Talent Officer (Age 58)

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by many different retail and institutional investors. Top institutional investors include Exchange Traded Concepts LLC (0.05%) and Diversified Trust Co (0.04%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Jeffrey S Points, Martha Goldberg Aronson, Sandra Sedo and Scott R Ward. View institutional ownership trends for Cardiovascular Systems.

Which major investors are buying Cardiovascular Systems stock?

CSII stock was purchased by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC, and Diversified Trust Co. Company insiders that have bought Cardiovascular Systems stock in the last two years include Martha Goldberg Aronson, and Scott R Ward. View insider buying and selling activity for Cardiovascular Systems.

How do I buy shares of Cardiovascular Systems?

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $27.86.

How big of a company is Cardiovascular Systems?

Cardiovascular Systems has a market capitalization of $982.73 million and generates $248.02 million in revenue each year. The medical device company earns $-250,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Cardiovascular Systems employs 652 workers across the globe.

What is Cardiovascular Systems' official website?

The official website for Cardiovascular Systems is www.csi360.com.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.